Please see full Important Safety Information below in the pinned post and at https://injectaferhcp.com/#isi-fixedbottom
Select Important Safety Information
Injectafer® (ferric carboxymaltose injection) is indicated for the treatment of iron deficiency anemia (IDA) in adult and pediatric patients 1 year of age and older who have either intolerance or an unsatisfactory response to oral iron, and in adult patients who have non-dialysis dependent chronic kidney disease. Injectafer is also indicated for iron deficiency in adult patients with heart failure and New York Heart Association class II/III to improve exercise capacity.
Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Injectafer.
The most common side effects of Injectafer include:
• In adult patients: nausea, hypertension, flushing, injection site reactions, erythema, hypophosphatemia, and dizziness
• In pediatric patients: hypophosphatemia, injection site reactions, rash, headache, and vomiting
These are not all of the possible side effects of Injectafer.
The risk information provided here is not comprehensive. Please see Full Prescribing Information for Injectafer, including the bolded WARNING regarding hypersensitivity at InjectaferHCP.com.
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://injectaferhcp.com
- Keywords
- Walnut Creek.
Injectafer® (Ferric Carboxymaltose Injection) Hcp Questions
Injectafer® (Ferric Carboxymaltose Injection) Hcp's website is https://injectaferhcp.com
Injectafer® (Ferric Carboxymaltose Injection) Hcp's LinkedIn profile is https://www.linkedin.com/company/injectafer-hcp
Injectafer® (Ferric Carboxymaltose Injection) Hcp's industry is
Pharmaceutical Manufacturing
Injectafer® (Ferric Carboxymaltose Injection) Hcp's top competitors are
Ferric Machinery Inc.,
Shiva Ferric Private Limited,
Jolly Healthcare,
The Leukemia & Lymphoma Society - Eastern Pennsylvania & Delaware Region,
Annexus Health,
Invision,
Aoi,
Ferric, Inc.,
Phathom Pharmaceuticals,
Troikaa Pharmaceuticals Ltd..
Injectafer® (Ferric Carboxymaltose Injection) Hcp's categories are Pharmaceutical Manufacturing
